| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.3 | 2e-09 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |